4//SEC Filing
Graboyes Marc H 4
Accession 0001127602-12-025790
CIK 0001097264other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:45 PM ET
Size
5.7 KB
Accession
0001127602-12-025790
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Disposition from Tender
Common Stock
2012-09-04$1.82/sh−542,028$986,491→ 0 total
Footnotes (2)
- [F1]The Reporting Person tendered these shares pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Spectrum Pharmaceuticals, Inc. and Sapphire Acquisition Sub, Inc., dated April 4, 2012 (the "Merger Agreement"), and the Tender and Voting Agreement, dated April 4, 2012, by and among Spectrum Pharmaceuticals, Inc., Sapphire Acquisition Sub, Inc. and the Reporting Person.
- [F2]Includes 450,195 restricted stock units (an "RSU") awarded to the Reporting Person under the Issuer's 2008 Equity Incentive Plan tendered in exchange for a payment of $1.82 per underlying share of common stock, net of withholding, plus one contingent value right for each underlying share (a "CVR") pursuant to the tender offer described in the Tender Offer Statement on Schedule TO filed by Sapphire Acquisition Sub, Inc. with the Commission on April 16, 2012, as amended (the "Tender Offer"). Each RSU that was outstanding immediately prior to the Acceptance Time (as defined in the Merger Agreement) was canceled, with the holder of such RSU receiving in consideration of such cancellation, the payment described above.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001305811
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:45 PM ET
- Size
- 5.7 KB